2026-04-14T00:13:14Zhttps://recercat.cat/oai/requestoai:recercat.cat:2445/1190832025-12-05T00:01:33Zcom_2072_1057col_2072_478917
RECERCAT
author
Lazarus, Jeffrey V.
author
Sperle, Ida
author
Spina, Alexander
author
Rockstroh, Jürgen Kurt
2018-01-17T16:19:05Z2018-01-17T16:19:05Z2016-102017-11-22T19:00:00Z
AIM: To investigate whether or not key populations affected by
hepatitis B and hepatitis C are being tested sufficiently for
these diseases throughout the European region. METHODS: We
searched MEDLINE and EMBASE for studies on HBV and HCV testing
in the 53 Member States of the World Health Organization
European Region following PRISMA criteria. RESULTS: 136
English-language studies from 24 countries published between
January 2007 and June 2013 were found. Most studies took place
in 6 countries: France, Germany, Italy, the Netherlands, Turkey,
and the United Kingdom. 37 studies (27%) addressed HBV, 46 (34%)
HCV, and 53 (39%) both diseases. The largest categories of study
populations were people who use drugs (18%) and health care
patient populations (17%). Far fewer studies focused on
migrants, prison inmates, or men who have sex with men.
CONCLUSIONS: The overall evidence base on HBV and HCV testing
has considerable gaps in terms of the countries and populations
represented and validity of testing uptake data. More research
is needed throughout Europe to guide efforts to provide testing
to certain key populations.
cc by-nc-nd (c) CMJ, 2016 http://creativecommons.org/licenses/by-nc-nd/3.0/es/ info:eu-repo/semantics/openAccess
Hepatitis vírica
Europa
Hepatitis vírica
Europe
Are the testing needs of key European populations affected by
hepatitis B and hepatitis C being addressed? A scoping review of
testing studies in Europe
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion